Mental Health Blogs

Announced earlier today is a $25 million settlement between Eli Lilly and the State of Connecticut over allegations that the company illegally marketed Zyprexa for unapproved uses including dementia and ADHD. Lilly has already settled about $2.7 billion in other Zyprexa related claims.

Go to Source

Related posts:

1. Lilly Settles Mississippi Zyprexa Claims For $18.5 Million
2. Lilly, New Mexico Settle Zyprexa Case For $15.5 Million
3. Lilly Settles South Carolina Zyprexa Claims For $45 Million
4. Lilly Settles Zyprexa Lawsuit With State Of West Virginia
5. Lilly Settles Zyprexa Claims With Idaho